Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Fuji
Johnson and Johnson
Accenture
Teva
US Army
Fish and Richardson
Boehringer Ingelheim

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021041

« Back to Dashboard

NDA 021041 describes DEPOCYT, which is a drug marketed by Pacira Pharms Inc and is included in one NDA. Additional details are available on the DEPOCYT profile page.

The generic ingredient in DEPOCYT is cytarabine. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 021041
Tradename:DEPOCYT
Applicant:Pacira Pharms Inc
Ingredient:cytarabine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021041

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE, LIPOSOMAL;INJECTIONStrength10MG/ML
Approval Date:Apr 1, 1999TE:RLD:Yes

Expired US Patents for NDA 021041

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Julphar
Express Scripts
Chubb
Cipla
Harvard Business School
Colorcon
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.